1. Home
  2. IPHA vs XYF Comparison

IPHA vs XYF Comparison

Compare IPHA & XYF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Innate Pharma S.A. ADS

IPHA

Innate Pharma S.A. ADS

N/A

Current Price

$1.43

Market Cap

167.6M

Sector

Health Care

ML Signal

N/A

Logo X Financial each representing six

XYF

X Financial each representing six

N/A

Current Price

$5.74

Market Cap

179.1M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
IPHA
XYF
Founded
1999
2014
Country
France
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Finance: Consumer Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
167.6M
179.1M
IPO Year
2014
2018

Fundamental Metrics

Financial Performance
Metric
IPHA
XYF
Price
$1.43
$5.74
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
★ $6.67
N/A
AVG Volume (30 Days)
17.5K
★ 39.0K
Earning Date
09-17-2026
11-19-2026
Dividend Yield
N/A
★ 11.92%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$390.56
N/A
Revenue Next Year
$143.06
N/A
P/E Ratio
★ N/A
$0.90
Revenue Growth
N/A
N/A
52 Week Low
$1.17
$3.30
52 Week High
$2.71
$12.57

Technical Indicators

Market Signals
Indicator
IPHA
XYF
Relative Strength Index (RSI) 42.83 66.38
Support Level $1.38 $4.64
Resistance Level $1.59 $5.84
Average True Range (ATR) 0.07 0.21
MACD 0.01 0.06
Stochastic Oscillator 39.29 91.63

Price Performance

Historical Comparison
IPHA
XYF

About IPHA Innate Pharma S.A. ADS

Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. The company's approach includes therapeutic modalities such as monoclonal antibodies, multispecific NK cell engagers through its ANKET platform, and antibody-drug conjugates (ADC). Its portfolio includes lacutamab, which is being studied for cutaneous T-cell lymphomas and peripheral T-cell lymphomas, and monalizumab, which is being developed in collaboration with AstraZeneca for non-small cell lung cancer. The company's revenue mainly consists of revenues from collaboration and licensing agreements and government financing for research expenditure in the form of research tax credits, as well as other grants.

About XYF X Financial each representing six

X Financial is a Cayman Islands-based technology-driven personal finance company. Along with its subsidiaries, the firm provides diversified investment opportunities to investors in China through its wealth management platform, Xiaoying Wealth Management. Loan products offered by the company include Xiaoying Card Loan, Xiaoying Preferred Loan, and Xiaoying Housing Loan. The company generates revenue from loan facilitation service, post-origination service, guarantee services provided and financing income.

Share on Social Networks: